AG
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
5 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Vice President of Global Government Affairs
Disclosed on LD-2 filings
Career
CG
Specific issues
EPA regulation of Ethylene Oxide NESHAP Rule and Re-Registration FIFRA PID Rule PFAS issues: Fluoropolymers
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the "American Privacy Rights Act of 2024" provisions covering biomedical research and HIPAA
Patent legislation: beneficiary owner
Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization